Agios Pharmaceuticals: Truist Securities cuts target price to $35 from $37
AGIO•Truist Securities cut its target price for Agios Pharmaceuticals to $35 from $37.
Related News
Ardent Health Inc: BMO raises target price to $16 from $11
ARDT•
J.P. Morgan's voting rights in Inventiva fall below 5% to 4.99%
IVA•
Eli Lilly & Hims & Hers Health announce agreement to expand access to Zepbound & Foundayo
LLY•
SunCar appoints Eric H. Zhang as CFO
SDA•
EPR Properties: Truist Securities raises target price to $65 from $61
EPR•